The molecular formula of Sibutramine active substance was developed by pharmaceutical company Knoll Pharmaceuticals. In 1975, Knoll Pharmaceuticals became part of the German chemical company BASF. On June 30, 2002, BASF sold the formula of Sibutramine to Abbott Laboratories Limited pharmaceutical company.
The FDA approved Sibutramine for the exogenous obesity treatment in 1997. In the USA and Canada Abbott Laboratories was selling Sibutramine diet pills under the brand name Meridia. In many European countries, Sibutramine pills from Abbott were sold under the brand names Reductil and Raductil. In NZ, Sibutramine diet pills from Abbott were sold under the brand names Ectiva, Reduxade, Meridia, Zytrim and Reductil.
In 2010, diet pills Sibutramine were withdrawn from the pharmaceutical market in most countries. The reason for withdrawal of Sibutramine was the results of post-marketing studies, which demonstrated that the anti-obesity drug Sibutramine could cause cardiovascular disorders (including heart attack, stroke).
It should be noted that in some Latin American countries, Sibutramine pills from Abbott Laboratories are still being sold. For example, one of the manufacturers and distributors of Sibutramine diet pills in Peru is Abbott Company. This pharmaceutical company has a license to sell Sibutramine pills under the brand name Reductil. The cost of one Reductil (Sibutramine) 10mg pill in Peru is about $2 US.
If you want to buy Sibutramine pills, but do not know under what brand names they are sold in the pharmacies, you can get this information from physician or pharmacist. It is possible to find information on brand names of Sibutramine pills in your city on the obesity forums.